Merck ends trial of potential Alzheimer's drug verubecestat

MeSH terms

• Alzheimer Disease / cerebrospinal fluid
• Alzheimer Disease / drug therapy*
• Amyloid / cerebrospinal fluid
• Amyloid / drug effects
• Antibodies, Monoclonal, Humanized / pharmacology
• Antibodies, Monoclonal, Humanized / therapeutic use
• Clinical Trials as Topic*
• Cyclic S-Oxides / pharmacology
• Cyclic S-Oxides / therapeutic use*
• Drug Industry* / methods
• Humans
• Nootropic Agents / pharmacology
• Nootropic Agents / therapeutic use*
• Severity of Illness Index
• Thiadiazines / pharmacology
• Thiadiazines / therapeutic use*